Dainippon Lays Out R&D Table Ahead Of Latuda Challenges

Focus On Novel Schizophrenia Candidate

 
• By Ian Haydock
  
Schizophrenia
CNS Remains A Key Focus For Sumitomo Dainippon • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D